Showing results (151-160 of 216) with videos related to
Sort By:
Pageof 22
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 31, 2017
[A Case of Recurrent Esophageal Cancer Treated with Salvage Lymphadenectomy after Definitive Chemoradiotherapy]Kazuki Kano, Tsutomu Sato, Yukio Maezawa, et al.Journal of Cancer Research and Clinical Oncology|September 5, 2015
Clinical significance of IGF1R gene expression in patients with Stage II/III gastric cancer who receive curative surgery and adjuvant chemotherapy with S-1Koji Numata, Takashi Oshima, Kentaro Sakamaki, et al.Anticancer Research|April 30, 2022
The Systemic Inflammation Score Is an Independent Prognostic Factor for Esophageal Cancer Patients who Receive Curative TreatmentToru Aoyama, Mihwa Ju, Keisuke Komori, et al.Oncology Letters|August 8, 2024
Prognostic value of computed tomography‑derived skeletal muscle index and radiodensity in patients with gastric cancer after curative gastrectomyItaru Hashimoto, Keisuke Komori, Yukio Maezawa, et al.In Vivo (Athens, Greece)|June 27, 2024
The Systemic Immune-inflammation Index Is an Independent Prognostic Factor for Gastric Cancer Patients Who Receive Curative TreatmentToru Aoyama, Yukio Maezawa, Itaru Hashimoto, et al.Anticancer Research|April 3, 2020
Effect of Muscle Mass Loss After Esophagectomy on Prognosis of Oesophageal CancerYota Shimoda, Takanobu Yamada, Keisuke Komori, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 27, 2012
[A case of gastric small cell carcinoma with metastatic liver tumors responding to surgery and chemotherapy]Toru Aoyama, Takaki Yoshikawa, Junya Shirai, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 27, 2012
[Case of stage IIB gastric cancer with positive margin treated with sequential therapy consisting of S-1, chemoradiation therapy with paclitaxel and CDDP, and S-1 after surgery]Toru Aoyama, Takaki Yoshikawa, Junya Shirai, et al.Anticancer Research|March 27, 2024
The CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for Gastric Cancer Patients who Receive Curative TreatmentToru Aoyama, Yukio Maezawa, Itaru Hashimoto, et al.Annals of Surgical Oncology|January 15, 2016
Risk Factors for the Loss of Lean Body Mass After Gastrectomy for Gastric CancerToru Aoyama, Tsutomu Sato, Kenki Segami, et al.Pageof 22